Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Myofibroblasts, regeneration or renal fibrosis--is there a decisive hint?

Lindquist JA, Mertens PR.

Nephrol Dial Transplant. 2013 Nov;28(11):2678-81. doi: 10.1093/ndt/gft247. Epub 2013 Aug 23.

PMID:
23975753
2.

Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis.

LeBleu VS, Teng Y, O'Connell JT, Charytan D, Müller GA, Müller CA, Sugimoto H, Kalluri R.

Nat Med. 2013 Feb;19(2):227-31. doi: 10.1038/nm.2989. Epub 2013 Jan 27.

3.

Myofibroblast phenotypes expression in experimental renal scarring.

Muchaneta-Kubara EC, el Nahas AM.

Nephrol Dial Transplant. 1997 May;12(5):904-15.

PMID:
9175042
4.

Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis.

Takeji M, Moriyama T, Oseto S, Kawada N, Hori M, Imai E, Miwa T.

J Biol Chem. 2006 Dec 29;281(52):40193-200. Epub 2006 Nov 6.

6.

Myofibroblasts in experimental hydronephrosis.

Diamond JR, van Goor H, Ding G, Engelmyer E.

Am J Pathol. 1995 Jan;146(1):121-9.

7.

Fibroblasts and myofibroblasts in renal fibrosis.

Meran S, Steadman R.

Int J Exp Pathol. 2011 Jun;92(3):158-67. doi: 10.1111/j.1365-2613.2011.00764.x. Epub 2011 Feb 28. Review.

9.

Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition.

Fintha A, Gasparics Á, Fang L, Erdei Z, Hamar P, Mózes MM, Kökény G, Rosivall L, Sebe A.

Am J Pathol. 2013 Feb;182(2):388-400. doi: 10.1016/j.ajpath.2012.10.009. Epub 2012 Nov 22.

PMID:
23178076
11.

Thy-1 expression, a possible marker of early myofibroblast development, in renal tubulointerstitial fibrosis induced in rats by cisplatin.

Yuasa T, Juniantito V, Ichikawa C, Yano R, Izawa T, Kuwamura M, Yamate J.

Exp Toxicol Pathol. 2013 Jul;65(5):651-9. doi: 10.1016/j.etp.2012.07.005. Epub 2012 Aug 11.

PMID:
22884260
12.

Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R.

J Am Soc Nephrol. 2008 Dec;19(12):2282-7. doi: 10.1681/ASN.2008050513. Epub 2008 Nov 5.

13.

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice.

Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN, Fehling HJ, Fukatsu A, Minegishi N, Kita T, Kimura T, Okano H, Yamamoto M, Yanagita M.

J Clin Invest. 2011 Oct;121(10):3981-90. doi: 10.1172/JCI57301. Epub 2011 Sep 12.

15.

Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis.

Sugiura H, Yoshida T, Shiohira S, Kohei J, Mitobe M, Kurosu H, Kuro-o M, Nitta K, Tsuchiya K.

Am J Physiol Renal Physiol. 2012 May 15;302(10):F1252-64. doi: 10.1152/ajprenal.00294.2011. Epub 2012 Feb 15.

16.

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Galgano MT, Hampton GM, Frierson HF Jr.

Mod Pathol. 2006 Jun;19(6):847-53.

17.

Bcl-3 is a novel biomarker of renal fibrosis in chronic kidney disease.

Chen R, Wang L, Liu S, Chen X, Hu Y, Liu H, Zhang H, Jiang Y, Wang Q, Ye D, Li L, Liu D, Pan X, Wei L, Li X, Zhang X.

Oncotarget. 2017 Oct 9;8(57):97206-97216. doi: 10.18632/oncotarget.21692. eCollection 2017 Nov 14.

PMID:
29228604
18.

Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.

Wan J, Wang Y, Cai G, Liang J, Yue C, Wang F, Song J, Wang J, Liu M, Luo J, Li L.

Oncotarget. 2016 Oct 18;7(42):67748-67759. doi: 10.18632/oncotarget.11682.

19.

Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.

Choi DE, Jeong JY, Lim BJ, Chang YK, Na KR, Shin YT, Lee KW.

J Urol. 2011 Aug;186(2):694-701. doi: 10.1016/j.juro.2011.03.122. Epub 2011 Jun 17. Erratum in: J Urol. 2011 Oct;186(4):1560.

PMID:
21683401

Supplemental Content

Support Center